Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

1 source entries across 1 studies. This list may not include all unresolved or historical entries.

  • Elivaldogene autotemcelRegistry product

    Linked study entry; product equivalence not established

    Formulation reported by source: DISPERSION FOR INFUSION

    View study and source

Success Metrics

Active Trials
1(100%)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

1

all time

Status Distribution
Active(1)

Detailed Status

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
1
Active
1
Success Rate
N/A

Trials by Status

active_not_recruiting1100%

Recent Activity

1 active trials
Showing 1 of 1
active_not_recruiting

Long-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product

NCT02698579

Clinical Trials (1)

Showing 1 of 1 trials
NCT02698579

Long-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product

Active Not Recruiting

All 1 trials loaded

Drug Details

Intervention Type
Type not reported
Total Trials
1